Contents Issue 107 • June 2021 In association with Rewriting the supply chain for a post-pandemic world Covid-19 highlighted weak points in the pharma supply chain, but how can this be avoided in the future? IN DEPTH Creating an oral Covid-19 vaccine Comment Marketing oncology drugs in Asia Briefing Industry news Pharma industry briefing Covid-19 briefing Comment New Chinese Breakthrough Therapy designation attracts foreign companies Novel advancements for endometrial cancer patients Marketing an oncology drug in Asia The biopharma revolution In Depth Developing an oral Covid-19 vaccine Improving care for rare diseases in India What’s in a drug name? Focus on the patient, not the pill Academic-industry collaboration Rewriting the pharma supply chain In Data Inside the deal Deals analysis Market data 02/24/2024 02:03:10
Comment
Marketing oncology drugs in Asia